- Home
- Advocacy
- MIPS for Pathologists
- 2018 Pathology Quality Measures
In 2018, the Pathologists Quality Registry offered 17 quality reporting measures all developed by the CAP. Eight were Quality Payment Program (QPP) measures to be reported through a registry or billing claims. The remaining nine were specific pathology measures approved by the CMS as qualified clinical data registry (QCDR) measures—exclusively available in the Pathologists Quality Registry.
Pathologists Quality Registry QPP Measures
These measures were available for reporting to the CMS using the Pathologists Quality Registry, through billing/claims, and other registries.
| QPP 99: Breast Cancer Resection Pathology Reporting Registry and Claims Specifications |
| QPP 100: Colorectal Cancer Resection Pathology Reporting Registry and Claims Specifications |
| QPP 249: Barrett Esophagus Pathology Reporting Registry and Claims Specifications |
| QPP 250: Radical Prostatectomy Pathology Reporting Registry and Claims Specifications |
| QPP 251: Evaluation of HER2 for Breast Cancer Patients Registry and Claims Specifications |
| QPP 395: Lung Cancer Reporting (biopsy/cytology specimens)** Registry and Claims Specifications |
| QPP 396: Lung Cancer Reporting (resection specimens)** Registry and Claims Specifications |
| QPP 397: Melanoma Reporting** Registry and Claims Specifications |
Pathologists Quality Registry QCDR Measures
These measures can be reported to the CMS only with the Pathologists Quality Registry.
** = outcome or high-priority measure
Resources
Claims-Based Instruction Sheet
The CAP developed a Claims-Based Instruction Sheet to help you submit data on quality measures for MIPS through claims. The corresponding 2018 QPP Reporting Codes can help on which codes to report.